Gene · 5406
Papers3,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,840
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemical Profile and Healthy Properties of Sicilian Diplotaxis harra subsp. crassifolia (Raf.) Maire. | Molecules | 2024 | 38893326 | PubTator, text mining | PubMed |
| Compartmentalised enzyme-induced phase transformations in self-assembling lipid systems. | J Colloid Interface Sci | 2024 | 38838633 | PubTator, text mining | PubMed |
| Morin inhibits the activity of pancreatic lipase and adipogenesis. | Eur J Pharmacol | 2024 | 38830457 | PubTator, text mining | PubMed |
| A dual mediation model of the association between principal inclusive leadership and teacher innovative behavior. | Sci Rep | 2024 | 38811695 | PubTator, text mining | PubMed |
| Inquiry lipaseoring the mechanism of pancreatic lipase inhibition by isovitexin based on multispectral method and enzyme inhibition assay. | Luminescence | 2024 | 38769927 | PubTator, text mining | PubMed |
| Exploring the inhibitory action of betulinic acid on key digestive enzymes linked to diabetes via in vitro and computational models: approaches to anti-diabetic mechanisms. | SAR QSAR Environ Res | 2024 | 38764437 | PubTator, text mining | PubMed |
| The bile salt/phospholipid ratio determines the extent of in vitro intestinal lipolysis of triglycerides: Interfacial and emulsion studies. | Food Res Int | 2024 | 38763671 | PubTator, text mining | PubMed |
| Chemo-profiling and exploring therapeutic potential of Momordica dioica Roxb. ex Willd. for managing metabolic related disorders: In-vitro studies, and docking based approach. | J Ethnopharmacol | 2024 | 38759763 | PubTator, text mining | PubMed |
| Anti-diabetic, anti-pancreatic lipase, and anti-protein glycation potential of Irvingia gabonensis stem bark extracts: in vitro and in silico studies. | In Silico Pharmacol | 2024 | 38751710 | PubTator, text mining | PubMed |
| Anti-Obesity Therapeutic Targets Studied In Silico and In Vivo: A Systematic Review. | Int J Mol Sci | 2024 | 38731918 | PubTator, text mining | PubMed |
| Beaconet: A Reference-Free Method for Integrating Multiple Batches of Single-Cell Transcriptomic Data in Original Molecular Space. | Adv Sci (Weinh) | 2024 | 38711214 | PubTator, text mining | PubMed |
| Chemical Profile and Bioactivity of Rubus idaeus L. Fruits Grown in Conventional and Aeroponic Systems. | Plants (Basel) | 2024 | 38674524 | PubTator, text mining | PubMed |
| Enzyme modified biodegradable plastic preparation and performance in anaerobic co-digestion with food waste. | Bioresour Technol | 2024 | 38670291 | PubTator, text mining | PubMed |
| In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides. | Bioresour Bioprocess | 2024 | 38647933 | PubTator, text mining | PubMed |
| Adjustments of the Phytochemical Profile of Broccoli to Low and High Growing Temperatures: Implications for the Bioactivity of Its Extracts. | Int J Mol Sci | 2024 | 38612494 | PubTator, text mining | PubMed |
| The effect of konjac glucomannan on enzyme kinetics and fluorescence spectrometry of digestive enzymes: An in vitro research from the perspective of macromolecule crowding. | Food Res Int | 2024 | 38609226 | PubTator, text mining | PubMed |
| Safety evaluation of an extension of use of the food enzyme triacylglycerol lipase from the non-genetically modified Mucor circinelloides strain AE-LMH. | EFSA J | 2024 | 38601868 | PubTator, text mining | PubMed |
Fatty acids characterisation by GC-MS, antiglycation effect at multiple stages and protection of erythrocytes cells from oxidative damage induced by glycation of albumin of Opuntia ficus-indica (L.) Mill seed oil cultivated in Eastern Morocco: Experimental and computational approaches. | J Ethnopharmacol | 2024 | 38570146 | PubTator, text mining | PubMed |
Evaluation of antioxidant, antidiabetic and antiobesity potential of phenylpropanoids (PPs): Structure-activity relationship and insight into action mechanisms against dual digestive enzymes by comprehensive technologies. | Bioorg Chem | 2024 | 38507999 | PubTator, text mining | PubMed |
| Exploring the enigmatic association between PNLIP variants and risk of chronic pancreatitis in a large Chinese cohort. | Pancreatology | 2024 | 38485544 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5406/papers?page=14